Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Tilray Brands Inc TLRY

Alternate Symbol(s):  T.TLRY

Tilray Brands, Inc. is a global lifestyle and consumer packaged goods company. The Company operates through four segments: Cannabis operations, Distribution business, Beverage alcohol business and Wellness business. The Cannabis operations, which encompasses the production, distribution, sale, co-manufacturing and advisory services of both medical and adult-use cannabis. The Beverage alcohol... see more

Recent & Breaking News (NDAQ:TLRY)

SHAREHOLDER ALERT: WeissLaw LLP Reminds TLRY, CBLI, AKER and OBLN Shareholders About Its Ongoing Investigations

PR Newswire March 19, 2021

The US CBD Market Could be Worth $3 Billion By 2023

Livemoney March 18, 2021

Aphria to Host Special Meeting of Shareholders on Wednesday, April 14, 2021 to Approve Proposed Aphria-Tilray Business Combination

Canada NewsWire March 15, 2021

SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Tilray, Inc. - TLRY

PR Newswire March 12, 2021

SHAREHOLDER ALERT: WeissLaw LLP Reminds NTWN, TLRY, CBLI, and AKER Shareholders About Its Ongoing Investigations

PR Newswire March 12, 2021

Tilray® Receives Approvals to Expand and Commercialize Medical Cannabis Products in New Zealand

Business Wire March 10, 2021

Aphria and Tilray announce launch of investor & consumer-based website

Stockhouse Editorial February 24, 2021

CBD Drink Market Unlocking Significant Growth Potential for Investors

Livemoney February 22, 2021

Tilray reports $271 million loss for 2020

Stockhouse Editorial February 18, 2021

Cannabis Reform Could Get a Major Boost in the U.S. this Year

Livemoney February 18, 2021

Tilray, Inc. Reports 2020 Full Fiscal Year and Fourth Quarter Results

Business Wire February 17, 2021

CBD-Infused Beverages Could Create Tremendous Investment Opportunity

Livemoney February 16, 2021

Tilray to Report 2020 Full Fiscal Year and Fourth Quarter Financial Results on February 17, 2021

Business Wire February 12, 2021

CBD Companies Could See New Highs in 2021 with Potential Reform

Livemoney February 10, 2021

Tilray® Announces Agreement with Grow Pharma to Import and Distribute Medical Cannabis Products in the United Kingdom

Business Wire February 9, 2021

TILRAY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Continues to Investigate Merger of Tilray, Inc. - TLRY

Business Wire February 4, 2021

Tilray® Exports First Shipment of Medical Cannabis to Spain

Business Wire February 4, 2021

Cannabis Reform Could be a Top Priority in 2021

Livemoney February 2, 2021

Tilray® Receives the First and Only Market Authorization to Offer Medical Cannabis Products in Portugal

Business Wire February 1, 2021

Tilray® Selected by French National Agency to Supply GMP-Certified Medical Cannabis Products in France

Business Wire January 26, 2021